Nymox Pharmaceuticals

$2.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+5.07%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NYMX and other stocks, options, and ETFs commission-free!

About NYMX

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer.

CEO
Paul Averback
Employees
3
Headquarters
Nassau, New Providence
Founded
1995
Market Cap
186.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
167.51K
High Today
$2.31
Low Today
$2.19
Open Price
$2.22
Volume
131.41K
52 Week High
$4.79
52 Week Low
$1.83

NYMX Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

BGH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure